Main Profile
Manufacturer
Description in a few words:
Founded in 1945 by Necip and Lale Barlas, LIBA remains a prominent family-owned pharmaceutical company in Turkey. LIBA’s primary goal is to improve the quality of people’s lives by targeting publicly demanded niche markets and products. Not only has this enabled LIBA to grow its expertise, but it has also allowed LIBA to treat patients that were previously untreatable due to the lack of necessary medications and knowledge. With its strong emphasis on ethical values and scientific advancements, LIBA will keep fulfilling its social commitments.
Current Leadership:
Nesrin Dağsoy, CEO
Founding Year:
1945 > Necip & Lale Barlas
Manufacturing
Main product categories or therapies of focus Ophthalmology remains LIBA’s flagship category. Dermatology, CNS and opiate dependence prevention are also areas where LIBA is prominent. Total number of delivered boxes/year Approx. 20.000.000 boxes/year
R&D
R&D focus
Ophthalmology remains LIBA’s flagship category. Dermatology, CNS and opiate dependence prevention are also areas where LIBA is prominent.
Exports
Export department recently founded.
In More Depth
Number of employees
103
GMP certificates
Existent and constantly validated by Turkish Authorities
Revenue or Growth Rate in past financial year
53%
USP/ or a differentiating fact
- First to develop regional managements
In the Ophthalmology area:
. first to introduce non-preservative medications
. first to introduce antiviral medications
Prominent partnerships/ clients
- Galderma
- Novartis
- Valeant
- Alcon
- G&L
- Indivior
- VISUfarma
- Besins
- Aspen
- NTC
Contact:
Website:
E-mail: